Spike proteins are the hallmark of SARS-Cov-2, which bind to ACE2 receptors that lead to cell and membrane fusion. To address and alleviate respiratory health issues, we at Shiban Pharma have ...

Spike proteins are the hallmark of SARS-Cov-2, which bind to ACE2 receptors that lead to cell and membrane fusion. To address and alleviate respiratory health issues, we at Shiban Pharma have ...

As scientists, we often think we understand a virus—its structure, its tricks, the way it moves through the body. But every ...

It's been five years since COVID-19 was declared a global pandemic. As SARS-CoV-2 shifts to endemic status, questions about ...

When the COVID-19 pandemic first began, we saw how quickly the SARS-CoV-2 virus evolved. New variants emerged with mutations that increased transmissibility or helped the virus evade our immune ...

It's been five years since COVID-19 was declared a global pandemic. As SARS-CoV-2 shifts to endemic status, questions about ...

Introduction: A new generation of mucosal vaccine against the ever-evolving SARS-CoV-2 is of great value to fight COVID-19. In previous studies, our groups developed a viral vector vaccine based on an ...

In this study, the adhesion-blocking dispirotripiperazine core compound PDSTP was evaluated against SARS-CoV-2 in vitro and in vivo. We demonstrated that the molecule was acceptably active against two ...

After more than a decade in the United States, nuclear physicist Liu Chang, whose research has been crucial in the journey to achieve fusion energy, has left Princeton University for a position at ...

Fusion power startups have long been plagued by one stubborn question: Will the technology work? But now, with net-positive fusion power no longer the stuff of science fiction, a fresh crop of ...